Your browser doesn't support javascript.
loading
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico mechanistic investigations.
Musa, Arafa; Ihmaid, Saleh K; Hughes, David L; Said, Musa A; Abulkhair, Hamada S; El-Ghorab, Ahmed H; Abdelgawad, Mohamed A; Shalaby, Khaled; Shaker, Mohamed E; Alharbi, Khalid Saad; Alotaibi, Nasser Hadal; Kays, Deborah L; Taylor, Laurence J; Parambi, Della Grace Thomas; Alzarea, Sami I; Al-Karmalawy, Ahmed A; Ahmed, Hany E A; El-Agrody, Ahmed M.
Afiliação
  • Musa A; Department of Pharmacognosy, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Ihmaid SK; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Jadara University, Irbid, Jordon.
  • Hughes DL; School of Chemistry, University of East Anglia, Norwich, UK.
  • Said MA; Chemistry Department, College of Sciences, Taibah University, Medina, Saudi Arabia.
  • Abulkhair HS; Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
  • El-Ghorab AH; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Horus University-Egypt, International Coastal Road, New Damietta, Egypt.
  • Abdelgawad MA; Department of Chemistry, College of Science, Jouf university, Sakaka, Aljouf, Saudi Arabia.
  • Shalaby K; Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf university, Sakaka, Aljouf, Saudi Arabia.
  • Shaker ME; Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia.
  • Alharbi KS; Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Alotaibi NH; Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Kays DL; Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Taylor LJ; School of Chemistry, University of Nottingham, University Park, Nottingham, UK.
  • Parambi DGT; School of Chemistry, University of Nottingham, University Park, Nottingham, UK.
  • Alzarea SI; Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf university, Sakaka, Aljouf, Saudi Arabia.
  • Al-Karmalawy AA; Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Aljouf, Saudi Arabia.
  • Ahmed HEA; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
  • El-Agrody AM; Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
J Biomol Struct Dyn ; 41(21): 12411-12425, 2023.
Article em En | MEDLINE | ID: mdl-36661285

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Pirazolonas / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Pirazolonas / Antineoplásicos Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article